Imophoron
PrivateLast Round
Seed
Jul 6, 2023
Total Funding Raised
$8.49M
Company Overview
Imophoron operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Seed round in July 2023.
Imophoron is a biotechnology company developing a novel, next-generation nanoparticle platform, ADDomer™, for the development of vaccines to combat infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imophoron Comparables
Compare Imophoron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Uvax Bio, LLC | 81% | |
| Osivax | 76% | |
| Tiba Biotech | 74% |
For institutional investors. Book with your work email.
Imophoron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 6, 2023 | ||||
| Seed | Oct 7, 2021 | ||||
| Grant | Dec 1, 2017 |
For institutional investors. Book with your work email.
Imophoron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Brain Corporation | Seed |
| Spin Up Science | Seed |
| Science Creates Ventures | Seed |
| Octopus Investments | Seed |
| Biotechnology and Biological Sciences Research Council | Grant |
| Octopus Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2023
Raised $3.05M from Octopus Investments, Global Brain, and Science Creates.
- Oct 7, 2021
$5.4M round led by Octopus Ventures and Science Creates Ventures
For institutional investors. Book with your work email.
Imophoron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Imophoron's valuation, stock price, and market status.
Is Imophoron a public or private company?
Imophoron is a private company.
What is the current stock price of Imophoron?
Imophoron is a private company, so its shares have no public market price. Caplight tracks Imophoron's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Imophoron worth (valuation)?
Valuation information for Imophoron is not publicly available.
Can I buy Imophoron stock?
Imophoron shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Imophoron's last funding round?
Imophoron's most recent funding round was Seed on July 6, 2023.
Who are the main investors in Imophoron?
Key investors in Imophoron include Spin Up Science, Science Creates Ventures, Octopus Ventures.
Will Imophoron IPO soon?
No public IPO plans have been announced for Imophoron.
How can I track Imophoron secondary market activity?
Caplight tracks bids, offers, and trades in Imophoron's shares on secondary markets.